An effective way to curb cancer mortality is to detect it early and initiate treatment, yet one of the most widely used screening tests for prostate cancer, prostate specific antigen test (PSA), has a high false positive rate (3–5). The gene discussed is KLK3; the disease is prostate carcinoma.